Amryt Pharma (AMYT) – Investor presentation at ShareSoc September 2018

Presentation by Amryt Pharma CCO, David Allmond.

Amryt Pharma plc is a commercial-stage specialty pharmaceutical company focused on developing and delivering treatments for patients with rare and orphan diseases. The Company is building a diversified portfolio of proprietary drugs to help address some of rare and debilitating illnesses.

The team – 00:27
The vision – 02:12
Amryt overview – 04:04
Commercial & development pipeline – 06:00
Strategy – 3 pillars of growth – 07:43
Lojuxta – 10:02
Epidermolysis Bullosa (EB) AP101 – 12:20
AP103 – building an EB franchise – Gene Therapy Platform – 18:26
In-License Opportunities – 21:07
Financials – 22:16
Investment case – 22:55
Q&A – 24:18

 

The presentation slides can be viewed here.

You might be interested in

LEAVE YOUR COMMENT

Your email address will not be published. Required fields are marked *